Inhibition of microRNA-33b in humanized mice ameliorates nonalcoholic steatohepatitis
Open Access
- 1 June 2023
- journal article
- research article
- Published by Life Science Alliance, LLC in Life Science Alliance
- Vol. 6 (8) , e202301902
Abstract
Nonalcoholic steatohepatitis (NASH) can lead to cirrhosis and hepatocellular carcinoma in their advanced stages; however, there are currently no approved therapies. Here, we show that microRNA (miR)-33b in hepatocytes is critical for the development of NASH. miR-33b is located in the intron of sterol regulatory element–binding transcription factor 1 and is abundantly expressed in humans, but absent in rodents. miR-33b knock-in (KI) mice, which have a miR-33b sequence in the same intron of sterol regulatory element–binding transcription factor 1 as humans and express miR-33b similar to humans, exhibit NASH under high-fat diet feeding. This condition is ameliorated by hepatocyte-specific miR-33b deficiency but unaffected by macrophage-specific miR-33b deficiency. Anti-miR-33b oligonucleotide improves the phenotype of NASH in miR-33b KI mice fed a Gubra Amylin NASH diet, which induces miR-33b and worsens NASH more than a high-fat diet. Anti-miR-33b treatment reduces hepatic free cholesterol and triglyceride accumulation through up-regulation of the lipid metabolism–related target genes. Furthermore, it decreases the expression of fibrosis marker genes in cultured hepatic stellate cells. Thus, inhibition of miR-33b using nucleic acid medicine is a promising treatment for NASH.Keywords
Funding Information
- MEXT | Japan Society for the Promotion of Science (17K09860)
- MEXT | Japan Society for the Promotion of Science (20K08904)
- MEXT | Japan Society for the Promotion of Science (17H04177)
- MEXT | Japan Society for the Promotion of Science (17H05599)
- MEXT | Japan Society for the Promotion of Science (20H03675)
- Japan Agency for Medical Research and Development (21ym0126013h0001)
This publication has 70 references indexed in Scilit:
- Increased Hepatic Synthesis and Dysregulation of Cholesterol Metabolism Is Associated with the Severity of Nonalcoholic Fatty Liver DiseaseCell Metabolism, 2012
- A High-Cholesterol Diet Exacerbates Liver Fibrosis in Mice via Accumulation of Free Cholesterol in Hepatic Stellate CellsGastroenterology, 2012
- Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglyceridesNature, 2011
- Hepatic Free Cholesterol Accumulates in Obese, Diabetic Mice and Causes Nonalcoholic SteatohepatitisGastroenterology, 2011
- miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signalingProceedings of the National Academy of Sciences, 2011
- Liver X Receptor Signaling Is a Determinant of Stellate Cell Activation and Susceptibility to Fibrotic Liver DiseaseGastroenterology, 2011
- MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 ( Srebp2 ) regulates HDL in vivoProceedings of the National Academy of Sciences, 2010
- Acute doxorubicin cardiotoxicity is associated with miR-146a-induced inhibition of the neuregulin-ErbB pathwayCardiovascular Research, 2010
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005
- Diminished Hepatic Response to Fasting/Refeeding and Liver X Receptor Agonists in Mice with Selective Deficiency of Sterol Regulatory Element-binding Protein-1cJournal of Biological Chemistry, 2002